Molecular characterization and clinical relevance of m<sup>6</sup>A regulators across 33 cancer types.
Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, Wang Q, Li X, Zhang Y, Xu J. · 2019
Read Molecular characterization and clinical relevance of m<sup>6</sup>A regulators across 33 cancer types. by Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, Wang Q, Li X, Zhang Y, Xu J. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6744659.txt.
Description
Li and co-authors mapped the regulators of m6A, a chemical mark on RNA, across 33 cancer types. The mark helps run many cell processes. The team analyzed genetic changes and activity levels of its regulators in more than 10,000 subjects. They asked how these regulators tie to cancer traits and patient outlook.
Genetic alterations in m6A regulators proved widespread. Their activity levels tracked closely with the activity of classic cancer pathways. Regulator patterns could sort patients by likely prognosis. One reader protein, IGF2BP3, stood out as a possible cancer-promoting gene across many types. The results form a resource for studying how this RNA marking layer feeds cancer.
Catalog record
| CREATOR | Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, Wang Q, Li X, Zhang Y, Xu J. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |